Health TrialsbyHealthPanel

PIVO Use for Blood Cultures in the Emergency Department

ConditionsSepsisDevice PerformanceEmergency Medicine
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorIntermountain Health Care, Inc.

About this trial

The investigators will implement a protocol for use of the PIVO device for blood culture collection in the emergency department. This protocol utilizes the device in various scenarios to reduce needlesticks while allowing for accurate and appropriate assessment of potential pathogens in the bloodstream. The study team will train staff on use of the device then monitor utilization and contamination rates among emergency department patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

This study evaluates patients in whom blood cultures are obtained in the emergency department during the study period. The primary population of interest is those in whom the PIVO device is used, with comparison to the overall population of patients in whom blood cultures are obtained.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • PIVO device, a needle-free blood draw device

    Device

    The PIVO device, a needle-free blood draw device, may be used through an IV to obtain a blood sample and extends beyond the IV to ideally reduce the potential for contamination and to improve success in obtaining a sample. Per Google AI: "PIVO™ by Velano Vascular stands for Peripheral IV Origin, a needle-free blood draw device that uses a patient's existing peripheral IV (PIV) line to collect blood, avoiding extra needle sticks and reducing pain, hemolysis, and contamination, facilitating the "One-Stick Hospital Stay" goal for better patient care."

Treatment groups

10,000 Participants
are divided into 2 treatment groups
Group A: Patients in whom PIVO is used1 intervention
Group B: Blood cultures obtained without PIVO use0 interventions

Trial outcomes

Primary outcomes

1

PIVO utilization

The investigators will assess utilization of the device for blood cultures obtained in the emergency department through review of the medical record and documentation of cases in which PIVO was used for blood cultures as a proportion of all blood cultures obtained.

Time frame
From baseline until 12 months after baseline
2

Contamination rates

The investigators will assess contamination rates for blood cultures obtained using the device compared to blood cultures obtained without the device.

Time frame
From baseline until 12 months after baseline

Secondary outcomes

1

Staff satisfaction and willingness to recommend the device

The investigators will survey staff who have utilized the PIVO device to assess their satisfaction with use and willingness to recommend this to others.

Time frame
Six months after study initiation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Intermountain Health Care, Inc.

Lead sponsor

Source ClinicalTrials.gov
Apply now